Literature DB >> 22984905

The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis.

Tomoyoshi Aoyagi1, Masayuki Nagahashi, Akimitsu Yamada, Kazuaki Takabe.   

Abstract

Sphingosine-1-phosphate (S1P) is a potent sphingolipid metabolite that regulates a number of biological processes critical for cancer. S1P produced inside cancer cells is exported and exerts its extracellular functions by binding to its specific receptors in an autocrine, paracrine, and/or endocrine manner, which is known as inside-out signaling. S1P is also known to exert its intracellular functions especially in the inflammatory process, but its relevance to cancer biology remains to be elucidated. Recently, there have been growing interests in the role of S1P in breast cancer progression, including angiogenesis and lymphangiogenesis. Our group demonstrated that activation of sphingosine kinase 1, the enzyme that catalyzes the phosphorylation of sphingosine to S1P, is a key step of this process. In this review, we will cover our current knowledge on the role of S1P signaling pathway in breast cancer progression with an emphasis on its role in tumor-induced lymphangiogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22984905      PMCID: PMC3444762          DOI: 10.1089/lrb.2012.0010

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  110 in total

1.  Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.

Authors:  Kenneth LaMontagne; Amanda Littlewood-Evans; Christian Schnell; Terence O'Reilly; Lorenza Wyder; Teresa Sanchez; Beatrice Probst; Jeannene Butler; Alexander Wood; Gene Liau; Eric Billy; Andreas Theuer; Timothy Hla; Jeanette Wood
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

2.  Essential role for sphingosine kinases in neural and vascular development.

Authors:  Kiyomi Mizugishi; Tadashi Yamashita; Ana Olivera; Georgina F Miller; Sarah Spiegel; Richard L Proia
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner.

Authors:  Nobuyoshi Kobayashi; Tsuyoshi Nishi; Takahiro Hirata; Akio Kihara; Takamitsu Sano; Yasuyuki Igarashi; Akihito Yamaguchi
Journal:  J Lipid Res       Date:  2005-12-21       Impact factor: 5.922

4.  Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses.

Authors:  Sindy H Wei; Hugh Rosen; Melanie P Matheu; M Germana Sanna; Sheng-Kai Wang; Euijung Jo; Chi-Huey Wong; Ian Parker; Michael D Cahalan
Journal:  Nat Immunol       Date:  2005-11-06       Impact factor: 25.606

5.  Role of sphingosine kinase 2 in cell migration toward epidermal growth factor.

Authors:  Nitai C Hait; Sukumar Sarkar; Hervé Le Stunff; Aki Mikami; Michael Maceyka; Sheldon Milstien; Sarah Spiegel
Journal:  J Biol Chem       Date:  2005-06-10       Impact factor: 5.157

6.  Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis.

Authors:  Tarek A Taha; Kazuyuki Kitatani; Mazen El-Alwani; Jacek Bielawski; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2005-12-30       Impact factor: 5.191

Review 7.  Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine.

Authors:  Denise G Hemmings
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04       Impact factor: 3.000

8.  Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells.

Authors:  Sukumar Sarkar; Michael Maceyka; Nitai C Hait; Steven W Paugh; Heidi Sankala; Sheldon Milstien; Sarah Spiegel
Journal:  FEBS Lett       Date:  2005-10-10       Impact factor: 4.124

Review 9.  Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics.

Authors:  Sheldon Milstien; Sarah Spiegel
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

10.  Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.

Authors:  Barbara Visentin; John A Vekich; Bradley J Sibbald; Amy L Cavalli; Kelli M Moreno; Rosalia G Matteo; William A Garland; Yiling Lu; Shuangxing Yu; Hassan S Hall; Vikas Kundra; Gordon B Mills; Roger A Sabbadini
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

View more
  31 in total

1.  Predictive and prognostic value of sphingosine kinase 1 expression in patients with invasive ductal carcinoma of the breast.

Authors:  Sung-Im Do; Hyun-Soo Kim; Kyungeun Kim; Hyunjoo Lee; In-Gu Do; Dong-Hoon Kim; Seoung Wan Chae; Jin Hee Sohn
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 2.  A tale of two models: mouse and zebrafish as complementary models for lymphatic studies.

Authors:  Jun-Dae Kim; Suk-Won Jin
Journal:  Mol Cells       Date:  2014-05-23       Impact factor: 5.034

Review 3.  Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering.

Authors:  Bernard Y K Binder; Priscilla A Williams; Eduardo A Silva; J Kent Leach
Journal:  Tissue Eng Part B Rev       Date:  2015-07-14       Impact factor: 6.389

Review 4.  DNA damage response and sphingolipid signaling in liver diseases.

Authors:  Masayuki Nagahashi; Yasunobu Matsuda; Kazuki Moro; Junko Tsuchida; Daiki Soma; Yuki Hirose; Takashi Kobayashi; Shin-Ichi Kosugi; Kazuaki Takabe; Masaaki Komatsu; Toshifumi Wakai
Journal:  Surg Today       Date:  2015-10-29       Impact factor: 2.549

5.  TGF-β/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression: IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION.

Authors:  Jiawei Zhao; Jingjing Liu; Jen-Fu Lee; Wenliang Zhang; Mustapha Kandouz; Garrett C VanHecke; Shiyou Chen; Young-Hoon Ahn; Fulvio Lonardo; Menq-Jer Lee
Journal:  J Biol Chem       Date:  2016-11-17       Impact factor: 5.157

6.  ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer.

Authors:  Akimitsu Yamada; Masayuki Nagahashi; Tomoyoshi Aoyagi; Wei-Ching Huang; Santiago Lima; Nitai C Hait; Aparna Maiti; Kumiko Kida; Krista P Terracina; Hiroshi Miyazaki; Takashi Ishikawa; Itaru Endo; Michael R Waters; Qianya Qi; Li Yan; Sheldon Milstien; Sarah Spiegel; Kazuaki Takabe
Journal:  Mol Cancer Res       Date:  2018-03-09       Impact factor: 5.852

7.  Host sphingosine kinase 1 worsens pancreatic cancer peritoneal carcinomatosis.

Authors:  Hiroaki Aoki; Masayo Aoki; Eriko Katsuta; Rajesh Ramanathan; Michael O Idowu; Sarah Spiegel; Kazuaki Takabe
Journal:  J Surg Res       Date:  2016-07-09       Impact factor: 2.192

8.  Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis.

Authors:  Junko Tsuchida; Masayuki Nagahashi; Masato Nakajima; Kazuki Moro; Kumiko Tatsuda; Rajesh Ramanathan; Kazuaki Takabe; Toshifumi Wakai
Journal:  J Surg Res       Date:  2016-06-16       Impact factor: 2.192

9.  High levels of sphingolipids in human breast cancer.

Authors:  Masayuki Nagahashi; Junko Tsuchida; Kazuki Moro; Miki Hasegawa; Kumiko Tatsuda; Ingrid A Woelfel; Kazuaki Takabe; Toshifumi Wakai
Journal:  J Surg Res       Date:  2016-05-20       Impact factor: 2.192

Review 10.  The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases.

Authors:  Masayuki Nagahashi; Kizuki Yuza; Yuki Hirose; Masato Nakajima; Rajesh Ramanathan; Nitai C Hait; Phillip B Hylemon; Huiping Zhou; Kazuaki Takabe; Toshifumi Wakai
Journal:  J Lipid Res       Date:  2016-07-26       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.